Literature DB >> 22891194

The Pain and Sleep Questionnaire three-item index (PSQ-3): a reliable and valid measure of the impact of pain on sleep in chronic nonmalignant pain of various etiologies.

Lindsay Ayearst1, Zoltan Harsanyi, Kenneth J Michalko.   

Abstract

BACKGROUND: Sleep disturbance is among the more common complaints reported by chronic pain patients. Because pain-related sleep disturbance may serve as a marker for the assessment of responses to treatment for chronic pain, inclusion of a measure designed to assess the impact of pain on sleep in clinical trial protocols is important, if not necessary. Measures typically used for this purpose lack scales specifically designed for the assessment of the impact of pain on sleep or are based on a single item. Single-item scales lack reliability and, therefore, validity.
OBJECTIVES: To investigate the psychometric properties of the five-item Pain and Sleep Questionnaire (PSQ) Index, which is embedded in the eight-item inventory, by applying an accepted methodology using retrospective analyses in controlled clinical trials in which the measure had been administered among patients with chronic nonmalignant pain.
METHODS: Data were pooled from nine independent, single-site, double-blind, randomized placebo-controlled clinical trials conducted over a period of approximately 10 years, the majority of which were cross-over designs. A cross-validation approach was adopted with exploratory and confirmatory factor analyses conducted to evaluate the underlying structure and dimensionality of the measure. Internal consistency reliability was evaluated using Cronbach's alpha coefficient. Mean score differences were used to assess the ability of the index to detect important treatment changes. Correlation coefficients were calculated between index scores and scores from other health-related outcome measures to evaluate the criterion validity of the index. Finally, predictive validity was assessed using multiple regression analyses.
RESULTS: Pooling the data resulted in a sample of 605 patients (65.5% female; mean age 55.7 years). Findings suggested a revised three-item PSQ Index (PSQ-3). The PSQ-3 demonstrated high internal consistency across samples (ranging from 0.82 to 0.93) and was sensitive to detecting meaningful treatment effects within different chronic pain categories. Moderate to strong correlations (r>0.40) between the PSQ-3 and other health-related outcome measures provided preliminary evidence for criterion-related validity. Results of multiple regression analyses demonstrated that the PSQ-3 accounted for between 29% and 40% of the variance in scores from other health-related outcome measures.
CONCLUSIONS: Results support the scoring of a revised three-item index for the assessment of the impact of pain on sleep. The revised index demonstrated acceptable levels of internal consistency and preliminary support for the structural, criterion-related and predictive validity of the index was achieved.

Entities:  

Mesh:

Year:  2012        PMID: 22891194      PMCID: PMC3411378          DOI: 10.1155/2012/635967

Source DB:  PubMed          Journal:  Pain Res Manag        ISSN: 1203-6765            Impact factor:   3.037


  52 in total

1.  Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial.

Authors:  Richard Langford; Frank McKenna; Stuart Ratcliffe; Jozef Vojtassák; Ute Richarz
Journal:  Arthritis Rheum       Date:  2006-06

2.  Sleep deprivation in chronic somatoform pain-effects on mood and pain regulation.

Authors:  Volker Busch; Joachim Haas; Tatjana Crönlein; Christoph Pieh; Peter Geisler; Göran Hajak; Peter Eichhammer
Journal:  Psychiatry Res       Date:  2011-07-31       Impact factor: 3.222

3.  Short sleep duration is independently associated with overweight and obesity in Quebec children.

Authors:  Jean-Philippe Chaput; Marie Lambert; Katherine Gray-Donald; Jennifer J McGrath; Mark S Tremblay; Jennifer O'Loughlin; Angelo Tremblay
Journal:  Can J Public Health       Date:  2011 Sep-Oct

4.  Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain.

Authors:  Neil A Hagen; Michael Thirlwell; John Eisenhoffer; Patricia Quigley; Zoltan Harsanyi; Andrew Darke
Journal:  J Pain Symptom Manage       Date:  2005-01       Impact factor: 3.612

5.  Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.

Authors:  C Peter N Watson; Dwight Moulin; Judith Watt-Watson; Allan Gordon; John Eisenhoffer
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

6.  Sleep and pain.

Authors:  Harvey Moldofsky
Journal:  Sleep Med Rev       Date:  2001-10       Impact factor: 11.609

7.  Re: Beaulieu AD, Peloso PM, Haraoui B, et al. Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain to to osteoarthritis: a randomized controlled trial. Pain Res Manage 2008; 13:103-10, and Thorne C, Beaulieu AD, Callaghan DJ, et. al. A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis. Pain Res Manage 2008; 13:93-102.

Authors:  Philip Champion
Journal:  Pain Res Manag       Date:  2008 Jul-Aug       Impact factor: 3.037

8.  Use of patient-reported sleep measures in clinical trials of pain treatment: a literature review and synthesis of current sleep measures and a conceptual model of sleep disturbance in pain.

Authors:  Jason C Cole; Dominique Dubois; Mark Kosinski
Journal:  Clin Ther       Date:  2007       Impact factor: 3.393

9.  Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.

Authors:  David A Fishbain; Jerry Hall; Adam L Meyers; Jill Gonzales; Craig Mallinckrodt
Journal:  J Pain Symptom Manage       Date:  2008-05-27       Impact factor: 3.612

10.  Pain relief and pain-related sleep disturbance with extended-release tramadol in patients with osteoarthritis.

Authors:  Mark Kosinski; Carmela Janagap; Kavita Gajria; Jeff Schein; John Freedman
Journal:  Curr Med Res Opin       Date:  2007-07       Impact factor: 2.580

View more
  12 in total

Review 1.  Neuromodulation in the Treatment of Painful Diabetic Neuropathy: A Review of Evidence for Spinal Cord Stimulation.

Authors:  Natalie H Strand; Adam R Burkey
Journal:  J Diabetes Sci Technol       Date:  2021-11-29

2.  High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled Trial.

Authors:  Erika A Petersen; Thomas G Stauss; James A Scowcroft; Elizabeth S Brooks; Judith L White; Shawn M Sills; Kasra Amirdelfan; Maged N Guirguis; Jijun Xu; Cong Yu; Ali Nairizi; Denis G Patterson; Kostandinos C Tsoulfas; Michael J Creamer; Vincent Galan; Richard H Bundschu; Neel D Mehta; Dawood Sayed; Shivanand P Lad; David J DiBenedetto; Khalid A Sethi; Johnathan H Goree; Matthew T Bennett; Nathan J Harrison; Atef F Israel; Paul Chang; Paul W Wu; Charles E Argoff; Christian E Nasr; Rod S Taylor; David L Caraway; Nagy A Mekhail
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2022-07-01

3.  Extent of sleep problems and relationship with severity of chronic pain using three validated sleep assessment tools.

Authors:  Rachel Vaughan; Helen F Galley; Saravana Kanakarajan
Journal:  Br J Pain       Date:  2021-11-12

4.  Imaging pain relief in osteoarthritis (IPRO): protocol of a double-blind randomised controlled mechanistic study assessing pain relief and prediction of duloxetine treatment outcome.

Authors:  Diane Reckziegel; Helen Bailey; William J Cottam; Christopher R Tench; Ravi P Mahajan; David A Walsh; Roger D Knaggs; Dorothee P Auer
Journal:  BMJ Open       Date:  2017-06-26       Impact factor: 2.692

5.  The health literacy questionnaire among the aged in Changsha, China: confirmatory factor analysis.

Authors:  Yiwei Huang; Tingting Ruan; Qiaoyun Yi; Tingting Wang; Zhihua Guo
Journal:  BMC Public Health       Date:  2019-09-04       Impact factor: 3.295

6.  High-Frequency Spinal Cord Stimulation at 10 kHz for the Treatment of Nonsurgical Refractory Back Pain: Design of a Pragmatic, Multicenter, Randomized Controlled Trial.

Authors:  Naresh Patel; Aaron Calodney; Leonardo Kapural; Rose Province-Azalde; Shivanand P Lad; Julie Pilitsis; Chengyuan Wu; Taissa Cherry; Jeyakumar Subbaroyan; Bradford Gliner; David Caraway
Journal:  Pain Pract       Date:  2020-09-26       Impact factor: 3.183

7.  Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial.

Authors:  Erika A Petersen; Thomas G Stauss; James A Scowcroft; Elizabeth S Brooks; Judith L White; Shawn M Sills; Kasra Amirdelfan; Maged N Guirguis; Jijun Xu; Cong Yu; Ali Nairizi; Denis G Patterson; Kostandinos C Tsoulfas; Michael J Creamer; Vincent Galan; Richard H Bundschu; Christopher A Paul; Neel D Mehta; Heejung Choi; Dawood Sayed; Shivanand P Lad; David J DiBenedetto; Khalid A Sethi; Johnathan H Goree; Matthew T Bennett; Nathan J Harrison; Atef F Israel; Paul Chang; Paul W Wu; Gennady Gekht; Charles E Argoff; Christian E Nasr; Rod S Taylor; Jeyakumar Subbaroyan; Bradford E Gliner; David L Caraway; Nagy A Mekhail
Journal:  JAMA Neurol       Date:  2021-06-01       Impact factor: 18.302

8.  Cross-cultural adaptation and validation of the Finnish version of the central sensitization inventory and its relationship with dizziness and postural control.

Authors:  Jani Mikkonen; Hannu Luomajoki; Olavi Airaksinen; Randy Neblett; Tuomas Selander; Ville Leinonen
Journal:  BMC Neurol       Date:  2021-03-31       Impact factor: 2.474

9.  High-Frequency Spinal Cord Stimulation at 10 kHz for the Treatment of Combined Neck and Arm Pain: Results From a Prospective Multicenter Study.

Authors:  Kasra Amirdelfan; Ricardo Vallejo; Ramsin Benyamin; Cong Yu; Thomas Yang; Richard Bundschu; Thomas L Yearwood; B Todd Sitzman; Bradford Gliner; Jeyakumar Subbaroyan; Anand Rotte; David Caraway
Journal:  Neurosurgery       Date:  2020-08-01       Impact factor: 4.654

10.  Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol.

Authors:  Rosalind Adam; Saravanakumar Kanakarajan; Uzunma Onyeakazi; Malachy Columb; Helen Galley
Journal:  BMJ Open       Date:  2020-03-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.